Guidelines for the diagnosis and treatment of chronic heart failure.

[1]  A. D. Cunningham,et al.  Left ventricular dysfunction, natriuretic peptides, and mortality in an urban population , 2001, Heart.

[2]  M. Domanski,et al.  A trial of the beta-blocker bucindolol in patients with advanced chronic heart failure. , 2001, The New England journal of medicine.

[3]  D. DeMets,et al.  Effect of carvedilol on survival in severe chronic heart failure. , 2001, The New England journal of medicine.

[4]  H. Dargie,et al.  Effect of carvedilol on outcome after myocardial infarction in patients with left-ventricular dysfunction: the CAPRICORN randomised trial , 2001, The Lancet.

[5]  A. Franco‐Cereceda,et al.  Partial left ventriculectomy for dilated cardiomyopathy: is this an alternative to transplantation? , 2001, The Journal of thoracic and cardiovascular surgery.

[6]  D. Grobbee,et al.  [Drug-induced heart failure]. , 1999, Nederlands tijdschrift voor geneeskunde.

[7]  G. Sutherland,et al.  Regional longitudinal strain distribution in the left and right ventricle in children after correction of tetralogy of fallot using ultrasound based strain rate imaging , 2001 .

[8]  P Toutouzas,et al.  A clinical appraisal of left atrial function. , 2001, European heart journal.

[9]  Luigi Tavazzi,et al.  Recommendations for exercise testing in chronic heart failure patients. , 2001, European heart journal.

[10]  J. Pell,et al.  Evidence of Improving Prognosis in Heart Failure: Trends in Case Fatality in 66 547 Patients Hospitalized Between 1986 and 1995 , 2000, Circulation.

[11]  K. Swedberg.  Importance of neuroendocrine activation in chronic heart failure. Impact on treatment strategies , 2000, European journal of heart failure.

[12]  M. Metra,et al.  Differential Effects of β-Blockers in Patients With Heart Failure , 2000 .

[13]  J. McMurray,et al.  Do patients with suspected heart failure and preserved left ventricular systolic function suffer from “diastolic heart failure” or from misdiagnosis? A prospective descriptive study , 2000, BMJ : British Medical Journal.

[14]  S. Kaul,et al.  Management of sexual dysfunction in patients with cardiovascular disease: recommendations of the Princeton Consensus Panel. , 2000, The American journal of cardiology.

[15]  P. Weissberg,et al.  Coronary artery calcification , 2000 .

[16]  J. Cleland,et al.  Clinical trials update: OPTIME‐CHF, PRAISE‐2, ALL‐HAT , 2000, European journal of heart failure.

[17]  W. Rand,et al.  Effects of losartan and captopril on left ventricular volumes in elderly patients with heart failure: results of the ELITE ventricular function substudy. , 2000, American heart journal.

[18]  M. Domanski,et al.  Light-to-moderate alcohol consumption and prognosis in patients with left ventricular systolic dysfunction. , 2000, Journal of the American College of Cardiology.

[19]  Salim Yusuf,et al.  Long-term ACE-inhibitor therapy in patients with heart failure or left-ventricular dysfunction: a systematic overview of data from individual patients , 2000, The Lancet.

[20]  Bertram Pitt,et al.  Effect of losartan compared with captopril on mortality in patients with symptomatic heart failure: randomised trial—the Losartan Heart Failure Survival Study ELITE II , 2000, The Lancet.

[21]  S G Thompson,et al.  Survival of patients with a new diagnosis of heart failure: a population based study , 2000, Heart.

[22]  C. Frampton,et al.  Treatment of heart failure guided by plasma aminoterminal brain natriuretic peptide (N-BNP) concentrations , 2000, The Lancet.

[23]  J. Cleland,et al.  Systematic review of the management of atrial fibrillation in patients with heart failure. , 2000, European heart journal.

[24]  Philip C. Carpino,et al.  Angiotensin ii receptor antagonists , 2000 .

[25]  R. McKelvie,et al.  Effects of metoprolol CR in patients with ischemic and dilated cardiomyopathy : the randomized evaluation of strategies for left ventricular dysfunction pilot study. , 2000, Circulation.

[26]  B. Massie,et al.  Ambulatory ventricular arrhythmias in patients with heart failure do not specifically predict an increased risk of sudden death. PROMISE (Prospective Randomized Milrinone Survival Evaluation) Investigators. , 2000, Circulation.

[27]  J. Cleland,et al.  Is the prognosis of heart failure improving? , 1999, Journal of the American College of Cardiology.

[28]  ICHAEL,et al.  THE EFFECT OF CARVEDILOL ON MORBIDITY AND MORTALITY IN PATIENTS WITH CHRONIC HEART FAILURE , 2000 .

[29]  K. Lee,et al.  A randomized study of the prevention of sudden death in patients with coronary artery disease. Multicenter Unsustained Tachycardia Trial Investigators. , 1999, The New England journal of medicine.

[30]  P A Poole-Wilson,et al.  Comparative effects of low and high doses of the angiotensin-converting enzyme inhibitor, lisinopril, on morbidity and mortality in chronic heart failure. ATLAS Study Group. , 1999, Circulation.

[31]  M. Kinoshita,et al.  Plasma brain natriuretic peptide level as a biochemical marker of morbidity and mortality in patients with asymptomatic or minimally symptomatic left ventricular dysfunction. Comparison with plasma angiotensin II and endothelin-1. , 1999, European heart journal.

[32]  J. Bigger,et al.  Risk stratification for coronary bypass surgery in patients with left ventricular dysfunction: analysis of the coronary artery bypass grafting patch trial database. , 1999, Circulation.

[33]  A. Camm,et al.  Dofetilide in patients with congestive heart failure and left ventricular dysfunction. Danish Investigations of Arrhythmia and Mortality on Dofetilide Study Group. , 1999, The New England journal of medicine.

[34]  A. Turpie,et al.  A comparison of enoxaparin with placebo for the prevention of venous thromboembolism in acutely ill medical patients. Prophylaxis in Medical Patients with Enoxaparin Study Group. , 1999, The New England journal of medicine.

[35]  B. Pitt,et al.  The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators. , 1999, The New England journal of medicine.

[36]  M. Antunes,et al.  Non-cardioplegic coronary surgery in patients with severe left ventricular dysfunction. , 1999, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[37]  G. Alexopoulos,et al.  Respiratory muscles performance is related to oxygen kinetics during maximal exercise and early recovery in patients with congestive heart failure. , 1999, Circulation.

[38]  J. Cleland,et al.  Heart failure update , 1999, European journal of heart failure.

[39]  A. Pasquet,et al.  Prognostic value of myocardial ischemia and viability in patients with chronic left ventricular ischemic dysfunction. , 1999, Circulation.

[40]  R. Novick,et al.  The Registry of the International Society for Heart and Lung Transplantation: sixteenth official report--1999. , 1999, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[41]  Andrew P. Kramer,et al.  Effect of pacing chamber and atrioventricular delay on acute systolic function of paced patients with congestive heart failure. The Pacing Therapies for Congestive Heart Failure Study Group. The Guidant Congestive Heart Failure Research Group. , 1999, Circulation.

[42]  Fach,et al.  Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in-Congestive Heart Failure (MERIT-HF) , 1999, The Lancet.

[43]  J. Cohn,et al.  Rationale and design of the Valsartan Heart Failure Trial: a large multinational trial to assess the effects of valsartan, an angiotensin-receptor blocker, on morbidity and mortality in chronic congestive heart failure. , 1999, Journal of cardiac failure.

[44]  H. Abu‐Saad,et al.  Effects of education and support on self-care and resource utilization in patients with heart failure. , 1999, European heart journal.

[45]  I. Dimopoulou,et al.  Contribution of Lung Function to Exercise Capacity in Patients with Chronic Heart Failure , 1999, Respiration.

[46]  J. Cleland,et al.  Sudden death in heart failure: vascular or electrical? , 1999, European journal of heart failure.

[47]  A Hofman,et al.  Prevalence of heart failure and left ventricular dysfunction in the general population; The Rotterdam Study. , 1999, European heart journal.

[48]  K. Bailey,et al.  Congestive heart failure in the community: trends in incidence and survival in a 10-year period. , 1999, Archives of internal medicine.

[49]  CIBIS-II Investigators and Committees.  The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial , 1999, The Lancet.

[50]  J. McMurray,et al.  Importance of heart failure as a cause of death. Changing contribution to overall mortality and coronary heart disease mortality in Scotland 1979-1992. , 1998, European heart journal.

[51]  J. Deharo,et al.  Multisite Pacing as a Supplemental Treatment of Congestive Heart Failure: Preliminary Results of the Medtronic Inc. InSync Study , 1998, Pacing and clinical electrophysiology : PACE.

[52]  S. Lévy,et al.  Atrial fibrillation: current knowledge and recommendations for management. Working Group on Arrhythmias of the European Society of Cardiology. , 1998, European heart journal.

[53]  B. Fagerberg,et al.  Feasibility of a nurse-monitored, outpatient-care programme for elderly patients with moderate-to-severe, chronic heart failure. , 1998, European heart journal.

[54]  S. Stewart,et al.  Effects of a home-based intervention among patients with congestive heart failure discharged from acute hospital care. , 1998, Archives of internal medicine.

[55]  C M Kramer,et al.  Integrated approach to ischemic heart disease. The one-stop shop. , 1998, Cardiology clinics.

[56]  N. Smedira,et al.  Partial left ventriculectomy and mitral valve repair for end-stage congestive heart failure. , 1998, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[57]  S. Bolling,et al.  Intermediate-term outcome of mitral reconstruction in cardiomyopathy. , 1998, The Journal of thoracic and cardiovascular surgery.

[58]  H. Tunstall-Pedoe,et al.  Biochemical detection of left-ventricular systolic dysfunction , 1998, The Lancet.

[59]  Thierry C. Gillebert,et al.  How to diagnose diastolic heart failure , 1998 .

[60]  M. Keller,et al.  A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. , 1997, The New England journal of medicine.

[61]  P. Poole‐Wilson,et al.  Value of natriuretic peptides in assessment of patients with possible new heart failure in primary care , 1997, The Lancet.

[62]  Hugh Tunstall-Pedoe,et al.  Symptomatic and asymptomatic left-ventricular systolic dysfunction in an urban population , 1997, The Lancet.

[63]  J. Cohn,et al.  Effect of the calcium antagonist felodipine as supplementary vasodilator therapy in patients with chronic heart failure treated with enalapril: V-HeFT III. Vasodilator-Heart Failure Trial (V-HeFT) Study Group. , 1997, Circulation.

[64]  P. Ponikowski,et al.  Hormonal changes and catabolic/anabolic imbalance in chronic heart failure and their importance for cardiac cachexia. , 1997, Circulation.

[65]  A. Struthers,et al.  Aldosterone blockade reduces vascular collagen turnover, improves heart rate variability and reduces early morning rise in heart rate in heart failure patients. , 1997, Cardiovascular research.

[66]  P. Ponikowski,et al.  Depressed heart rate variability as an independent predictor of death in chronic congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. , 1997, The American journal of cardiology.

[67]  C. Mulrow,et al.  Can the clinical examination diagnose left-sided heart failure in adults? , 1997, JAMA.

[68]  L. Pierard,et al.  Myocardial viability. Stress echocardiography vs nuclear medicine. , 1997, European heart journal.

[69]  J. Cleland.  Anticoagulant and antiplatelet therapy in heart failure. , 1997, Current opinion in cardiology.

[70]  P. Ponikowski,et al.  Wasting as independent risk factor for mortality in chronic heart failure , 1997, The Lancet.

[71]  A. Skene,et al.  Randomised study of effect of ibopamine on survival in patients with advanced severe heart failure , 1997, The Lancet.

[72]  R. Doughty,et al.  Left ventricular remodeling with carvedilol in patients with congestive heart failure due to ischemic heart disease , 1997 .

[73]  S. Ogston,et al.  Cross sectional study of contribution of clinical assessment and simple cardiac investigations to diagnosis of left ventricular systolic dysfunction in patients admitted with acute dyspnoea , 1997, BMJ.

[74]  M. Nakashima,et al.  Thromboxane A2 synthetase inhibition suppresses cough induced by angiotensin converting enzyme inhibitors. , 1997, Life sciences.

[75]  Bertram Pitt,et al.  Randomised trial of losartan versus captopril in patients over 65 with heart failure (Evaluation of Losartan in the Elderly Study, ELITE) , 1997, The Lancet.

[76]  I. Holme,et al.  Accuracy and reproducibility of biplane two-dimensional echocardiographic measurements of left ventricular dimensions and function. , 1997, European heart journal.

[77]  E. J. Brown,et al.  The effect of digoxin on mortality and morbidity in patients with heart failure. , 1997, The New England journal of medicine.

[78]  Australia..  Randomised, placebo-controlled trial of carvedilol in patients with congestive heart failure due to ischaemic heart disease , 1997, The Lancet.

[79]  G. Lamas,et al.  Ventricular dysfunction and the risk of stroke after myocardial infarction. , 1997, The New England journal of medicine.

[80]  Usefulness of echocardiography in detecting left ventricular dysfunction in population-based studies (The Rotterdam Study). , 1997, The American journal of cardiology.

[81]  L. Erhardt,et al.  Simplified echocardiography in the diagnosis of heart failure. , 1997, Scandinavian cardiovascular journal : SCJ.

[82]  A. Moss,et al.  Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial Investigators. , 1996, The New England journal of medicine.

[83]  S. Dubner,et al.  Nonsustained ventricular tachycardia in severe heart failure. Independent marker of increased mortality due to sudden death. GESICA-GEMA Investigators. , 1996, Circulation.

[84]  J. A. Bowers,et al.  Carvedilol inhibits clinical progression in patients with mild symptoms of heart failure. US Carvedilol Heart Failure Study Group. , 1996, Circulation.

[85]  K. Adams,et al.  Carvedilol produces dose-related improvements in left ventricular function and survival in subjects with chronic heart failure. MOCHA Investigators. , 1996, Circulation.

[86]  A. Lazarus,et al.  Multisite Pacing for End‐Stage Heart Failure: Early Experience , 1996, Pacing and clinical electrophysiology : PACE.

[87]  F Boomsma,et al.  Prognostic value of heart rate variability during long-term follow-up in patients with mild to moderate heart failure. The Dutch Ibopamine Multicenter Trial Study Group. , 1996, Journal of the American College of Cardiology.

[88]  L. Tavazzi,et al.  Concomitant factors of decompensation in chronic heart failure. , 1996, The American journal of cardiology.

[89]  R. D'Agostino,et al.  Use of vital capacity for cardiac failure risk estimation in persons with coronary disease and left ventricular hypertrophy. , 1996, The American journal of cardiology.

[90]  G. Sutton,et al.  Objective assessment of the response to treatment of severe heart failure using a 9-minute walk test on a patient-powered treadmill. , 1996, Journal of cardiac failure.

[91]  M. Weinberger,et al.  Does increased access to primary care reduce hospital readmissions? Veterans Affairs Cooperative Study Group on Primary Care and Hospital Readmission. , 1996, The New England journal of medicine.

[92]  R. Falk,et al.  Should all patients with atrial fibrillation receive warfarin? Evidence from randomized clinical trials. , 1996, European heart journal.

[93]  T. Dormans,et al.  Chronic intermittent haemofiltration and haemodialysis in end stage chronic heart failure with oedema refractory to high dose frusemide. , 1996, Heart.

[94]  L. Sinoway,et al.  Hemodynamic effects of supplemental oxygen administration in congestive heart failure. , 1996, Journal of the American College of Cardiology.

[95]  P. Binkley,et al.  Role of spectral measures of heart rate variability as markers of disease progression in patients with chronic congestive heart failure not treated with angiotensin-converting enzyme inhibitors. , 1996, American heart journal.

[96]  J. Thomas,et al.  Prognostic value of dobutamine echocardiography in patients with left ventricular dysfunction. , 1996, Journal of the American College of Cardiology.

[97]  E. Aliot,et al.  A clinical trial of the angiotensin-converting-enzyme inhibitor trandolapril in patients with left ventricular dysfunction after myocardial infarction. Trandolapril Cardiac Evaluation (TRACE) Study Group. , 1995, The New England journal of medicine.

[98]  J. Seward,et al.  New index of combined systolic and diastolic myocardial performance: a simple and reproducible measure of cardiac function--a study in normals and dilated cardiomyopathy. , 1995, Journal of cardiology.

[99]  U. Elkayam,et al.  Prevention of tolerance to hemodynamic effects of nitrates with concomitant use of hydralazine in patients with chronic heart failure. , 1995, Journal of the American College of Cardiology.

[100]  R. Carney,et al.  A multidisciplinary intervention to prevent the readmission of elderly patients with congestive heart failure. , 1995, The New England journal of medicine.

[101]  P. Nihoyannopoulos,et al.  Plasma neuro-endocrine activity in very elderly subjects and patients with and without heart failure. , 1995, European heart journal.

[102]  C. Good,et al.  Diet and serum potassium in patients on ACE inhibitors. , 1995, JAMA.

[103]  P C Deedwania,et al.  Amiodarone in patients with congestive heart failure and asymptomatic ventricular arrhythmia. Survival Trial of Antiarrhythmic Therapy in Congestive Heart Failure. , 1995, The New England journal of medicine.

[104]  D. Brater,et al.  Bioavailability, pharmacokinetics, and pharmacodynamics of torsemide and furosemide in patients with congestive heart failure , 1995, Clinical pharmacology and therapeutics.

[105]  M. Quiñones,et al.  Effects of long-term enalapril therapy on cardiac structure and function in patients with left ventricular dysfunction. Results of the SOLVD echocardiography substudy. , 1995, Circulation.

[106]  S. Bolling,et al.  Early outcome of mitral valve reconstruction in patients with end-stage cardiomyopathy. , 1995, The Journal of thoracic and cardiovascular surgery.

[107]  B. Gersh,et al.  The utility of clinical, electrocardiographic, and roentgenographic variables in the prediction of left ventricular function. , 1995, The American journal of cardiology.

[108]  W. Wang,et al.  Chronic administration of aldosterone depresses baroreceptor reflex function in the dog. , 1994, Hypertension.

[109]  L. Wilkins.  A randomized trial of beta-blockade in heart failure. The Cardiac Insufficiency Bisoprolol Study (CIBIS). CIBIS Investigators and Committees. , 1994, Circulation.

[110]  J. Cleland,et al.  Increased alveolar/capillary membrane resistance to gas transfer in patients with chronic heart failure. , 1994, British heart journal.

[111]  S. Cerutti,et al.  Can power spectral analysis of heart rate variability identify a high risk subgroup of congestive heart failure patients with excessive sympathetic activation? A pilot study before and after heart transplantation. , 1994, British heart journal.

[112]  G. Lamas,et al.  N-terminal proatrial natriuretic factor. An independent predictor of long-term prognosis after myocardial infarction. , 1994, Circulation.

[113]  W. Gaasch,et al.  Left Ventricular Diastolic Dysfunction and Heart Failure , 1994 .

[114]  D. Mann,et al.  Basic mechanisms in congestive heart failure. Recognizing the role of proinflammatory cytokines. , 1994, Chest.

[115]  O. Alfieri,et al.  Echocardiography during infusion of dobutamine for identification of reversibly dysfunction in patients with chronic coronary artery disease. , 1994, Journal of the American College of Cardiology.

[116]  K. Channer,et al.  Combination diuretic treatment in severe heart failure: a randomised controlled trial. , 1994, British heart journal.

[117]  K. Swedberg,et al.  Beneficial effects of metoprolol in idiopathic dilated cardiomyopathy , 1993, The Lancet.

[118]  Bittner,et al.  Prediction of mortality and morbidity with a 6-minute walk test in patients with left ventricular dysfunction. SOLVD Investigators. , 1993, JAMA.

[119]  William J. Rogers,et al.  Prediction of Mortality and Morbidity With a 6-Minute Walk Test in Patients With Left Ventricular Dysfunction , 1993 .

[120]  G. Murray,et al.  Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure. The Acute Infarction Ramipril Efficacy (AIRE) Study Investigators , 1993 .

[121]  P. Poole‐Wilson,et al.  Relation of pathophysiologic mechanisms to outcome in heart failure. , 1993, Journal of the American College of Cardiology.

[122]  G A Ewy,et al.  Bedside cardiovascular examination in patients with severe chronic heart failure: importance of rest or inducible jugular venous distension. , 1993, Journal of the American College of Cardiology.

[123]  J. McMurray,et al.  Trends in hospitalization for heart failure in Scotland 1980-1990. , 1993, European heart journal.

[124]  A J Camm,et al.  Heart rate variability: from facts to fancies. , 1993, Journal of the American College of Cardiology.

[125]  K. Bailey,et al.  Circulating N-terminal atrial natriuretic peptide as a marker for symptomless left-ventricular dysfunction , 1993, The Lancet.

[126]  M. Packer.  How should physicians view heart failure? The philosophical and physiological evolution of three conceptual models of the disease. , 1993, The American journal of cardiology.

[127]  D. Mancini,et al.  Exertional Fatigue Due to Skeletal Muscle Dysfunction in Patients With Heart Failure , 1993, Circulation.

[128]  A. Donker,et al.  Spironolactone in congestive heart failure refractory to high-dose loop diuretic and low-dose angiotensin-converting enzyme inhibitor. , 1993, The American journal of cardiology.

[129]  D. Cooper,et al.  Returning to work after heart transplantation. , 1993, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[130]  T. MacDonald,et al.  Echocardiography in chronic heart failure in the community. , 1993, The Quarterly journal of medicine.

[131]  H Just,et al.  Intraindividual Reproducibility of Heart Rate Variability , 1992, Pacing and clinical electrophysiology : PACE.

[132]  G. Steinbeck,et al.  A comparison of electrophysiologically guided antiarrhythmic drug therapy with beta-blocker therapy in patients with symptomatic, sustained ventricular tachyarrhythmias. , 1992, The New England journal of medicine.

[133]  J. Cohn,et al.  Assessment of patient outcome with the Minnesota Living with Heart Failure questionnaire: reliability and validity during a randomized, double-blind, placebo-controlled trial of pimobendan. Pimobendan Multicenter Research Group. , 1992, American heart journal.

[134]  E. J. Brown,et al.  Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators. , 1992, The New England journal of medicine.

[135]  S. Yusuf,et al.  Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. , 1992, The New England journal of medicine.

[136]  K. Swedberg,et al.  Renal function in severe congestive heart failure during treatment with enalapril (the Cooperative North Scandinavian Enalapril Survival Study [CONSENSUS] Trial). , 1992, The American journal of cardiology.

[137]  K. Hammermeister,et al.  Implications of third heart sounds in patients with valvular heart disease. The Veterans Affairs Cooperative Study on Valvular Heart Disease. , 1992, The New England journal of medicine.

[138]  M. Landsman,et al.  Comparison between New York Heart Association classification and peak oxygen consumption in the assessment of functional status and prognosis in patients with mild to moderate chronic congestive heart failure secondary to either ischemic or idiopathic dilated cardiomyopathy. , 1992, The American journal of cardiology.

[139]  S. Yusuf,et al.  Effects of the angiotensin converting enzyme inhibitor enalapril on the long-term progression of left ventricular dysfunction in patients with heart failure. SOLVD Investigators. , 1992, Circulation.

[140]  G. Mancia,et al.  Reflex cardiovascular control in congestive heart failure. , 1992, The American journal of cardiology.

[141]  S Capewell,et al.  Decreased cardiac parasympathetic activity in chronic heart failure and its relation to left ventricular function. , 1992, British heart journal.

[142]  Y. Hirota,et al.  Clinical significance of normal cardiac silhouette in dilated cardiomyopathy--evaluation based upon echocardiography and magnetic resonance imaging. , 1992, Japanese circulation journal.

[143]  D. Cionni,et al.  Utility of the peak expiratory flow rate in the differentiation of acute dyspnea. Cardiac vs pulmonary origin. , 1992, Chest.

[144]  J. Cleland,et al.  Vascular tone in heart failure: the neuroendocrine-therapeutic interface. , 1991, British heart journal.

[145]  Salim Yusuf,et al.  Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. , 1991, The New England journal of medicine.

[146]  F. Tristani,et al.  A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure. , 1991, The New England journal of medicine.

[147]  J. Remes,et al.  Usefulness of M-mode echocardiography in the diagnosis of heart failure. , 1991, Cardiology.

[148]  R. Bonow,et al.  Radionuclide angiographic evaluation of left ventricular diastolic function. , 1991, Circulation.

[149]  R. Myerburg,et al.  Clinical, radiographic, and hemodynamic correlations in chronic congestive heart failure: conflicting results may lead to inappropriate care. , 1991, The American journal of medicine.

[150]  G. Sutton.  Epidemiologic aspects of heart failure. , 1990, American heart journal.

[151]  J. Cleland,et al.  Unsuspected renal artery stenosis in peripheral vascular disease. , 1990, BMJ.

[152]  S. Yusuf,et al.  Comparison of neuroendocrine activation in patients with left ventricular dysfunction with and without congestive heart failure. A substudy of the Studies of Left Ventricular Dysfunction (SOLVD). , 1990, Circulation.

[153]  J. Berning,et al.  Early estimation of risk by echocardiographic determination of wall motion index in an unselected population with acute myocardial infarction. , 1990, The American journal of cardiology.

[154]  S. Adamopoulos,et al.  Effects of physical training in chronic heart failure , 1990, The Lancet.

[155]  J. Marving,et al.  Symptoms and signs of heart failure in patients with myocardial infarction: reproducibility and relationship to chest X-ray, radionuclide ventriculography and right heart catheterization. , 1989, European heart journal.

[156]  M. Alam,et al.  Comparability of echocardiography and chest X‐ray following myocardial infarction , 1989, Journal of internal medicine.

[157]  L. Stevenson,et al.  The limited reliability of physical signs for estimating hemodynamics in chronic heart failure. , 1989, JAMA.

[158]  S. Rahimtoola,et al.  The hibernating myocardium. , 1989, American heart journal.

[159]  M. Alam,et al.  Atrioventricular valve plane displacement in healthy persons. An echocardiographic study. , 2009, Acta medica Scandinavica.

[160]  D. Cook,et al.  Breathlessness, lung function and the risk of heart attack. , 1988, European heart journal.

[161]  A. Moss,et al.  Estimating left ventricular ejection fraction after myocardial infarction by various clinical parameters. , 1988, The American journal of cardiology.

[162]  M. Lebowitz,et al.  Objective radiographic criteria to differentiate cardiac, renal, and injury lung edema. , 1988, Investigative radiology.

[163]  M. A. Spiteri,et al.  RELIABILITY OF ELICITING PHYSICAL SIGNS IN EXAMINATION OF THE CHEST , 1988, The Lancet.

[164]  J P Wexler,et al.  The relationship between left ventricular systolic function and congestive heart failure diagnosed by clinical criteria. , 1988, Circulation.

[165]  K. Swedberg,et al.  Effects of enalapril on mortality in severe congestive heart failure: results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). , 1988, The American journal of cardiology.

[166]  B. Simon,et al.  Comparison of the effect of sucralfate and ranitidine in reflux esophagitis. , 1987, The American journal of medicine.

[167]  S. Gottlieb,et al.  Prevention and reversal of nitrate tolerance in patients with congestive heart failure. , 1987, The New England journal of medicine.

[168]  C. Cipolla,et al.  Hemofiltration as short-term treatment for refractory congestive heart failure. , 1987, The American journal of medicine.

[169]  T. Hutchinson,et al.  Interobserver agreement by auscultation in the presence of a third heart sound in patients with congestive heart failure. , 1987, Chest.

[170]  G. Flaker,et al.  Comparative survival following permanent ventricular and dual-chamber pacing for patients with chronic symptomatic sinus node dysfunction with and without congestive heart failure. , 1987, American heart journal.

[171]  P. Poole‐Wilson,et al.  Untreated heart failure: clinical and neuroendocrine effects of introducing diuretics. , 1987, British heart journal.

[172]  F. Tristani,et al.  Effect of Vasodilator Therapy on Mortality in Chronic Congestive Heart Failure , 1986 .

[173]  P. Poole‐Wilson,et al.  Factors determining symptoms in heart failure: comparison of fast and slow exercise tests. , 1986, British heart journal.

[174]  G. Flaker,et al.  Comparative survival after permanent ventricular and dual chamber pacing for patients with chronic high degree atrioventricular block with and without preexistent congestive heart failure. , 1986, Journal of the American College of Cardiology.

[175]  Michael V. Green,et al.  Verapamil-induced improvement in left ventricular diastolic filling and increased exercise tolerance in patients with hypertrophic cardiomyopathy: short- and long-term effects. , 1985, Circulation.

[176]  R. Gunnar,et al.  Improvement in symptoms and exercise tolerance by metoprolol in patients with dilated cardiomyopathy: a double-blind, randomized, placebo-controlled trial. , 1985, Circulation.

[177]  G. Guyatt,et al.  The 6-minute walk: a new measure of exercise capacity in patients with chronic heart failure. , 1985, Canadian Medical Association journal.

[178]  J. Anderson,et al.  A randomized trial of low-dose beta-blockade therapy for idiopathic dilated cardiomyopathy. , 1985, The American journal of cardiology.

[179]  E. Gilpin,et al.  Usefulness of the chest x-ray for predicting abnormal left ventricular function after acute myocardial infarction. , 1984, American heart journal.

[180]  H. Denolin,et al.  The defintion of heart failure , 1983 .

[181]  C. Higgins,et al.  Extravascular lung water in patients with congestive heart failure. Difference between patients with acute and chronic myocardial disease. , 1983, Radiology.

[182]  H. Kundel,et al.  Digital analysis of chest radiographs in pulmonary vascular congestion. , 1982, Radiology.

[183]  J. Staessen,et al.  Rise in plasma concentration of aldosterone during long-term angiotensin II suppression. , 1981, The Journal of endocrinology.

[184]  K. Swedberg,et al.  Beneficial effects of long-term beta-blockade in congestive cardiomyopathy. , 1980, British heart journal.

[185]  Cockcroft Dw,et al.  Prediction of Creatinine Clearance from Serum Creatinine , 1976 .

[186]  A. L. Simon,et al.  Correlations between the chest film and hemodynamics in acute myocardial infarction. , 1973, Circulation.

[187]  C. Edmonds,et al.  Total-body potassium in hypertension patients during prolonged diuretic therapy. , 1972, Lancet.

[188]  W. Kannel,et al.  The natural history of congestive heart failure: the Framingham study. , 1971, The New England journal of medicine.

[189]  T. Petty,et al.  Long-term continuous oxygen therapy in chronic airway obstruction. Mortality in relationship to cor pulmonale, hypoxia, and hypercapnia. , 1970, Annals of internal medicine.

[190]  T. Killip,et al.  Treatment of myocardial infarction in a coronary care unit. A two year experience with 250 patients. , 1967, The American journal of cardiology.